Stay updated with breaking news from Ericaf Sim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For children younger than 5 years, the incidence of respiratory syncytial virus (RSV) hospitalization increased in 2021 and 2022 compared with 2015 to 2019.
Researchers found that for all ages, the incidence rate ratios of hospitalization increased in 2021 and 2022 vs 2015 to 2019.
Children aged 24 to 59 months were 4.86 times as likely to be hospitalized in 2022 vs 2015 to 2019.
The respiratory syncytial virus (RSV) vaccine Abrysvo is approved for use in pregnant individuals to prevent the RSV in infants up to 6 months of age.
The FDA approved the first maternal vaccine to protect infants against RSV from birth to 6 months.